These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 3997704

  • 1. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P.
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR, Krafczyk TL.
    Chemotherapy; 1980 Mar; 26(5):323-33. PubMed ID: 7389428
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Kedzia WB, Mirska I.
    J Chemother; 1989 Jul 30; 1(4 Suppl):367-8. PubMed ID: 16312443
    [No Abstract] [Full Text] [Related]

  • 8. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW, Boelaert J, Glibert B, Gordts B, Verbruggen AM.
    Am J Med; 1986 Jun 30; 80(6B):76-81. PubMed ID: 3089007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1988 May 30; 36(5):435-8. PubMed ID: 3136424
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H, Krcméry V.
    Chemotherapy; 1979 May 30; 25(1):23-9. PubMed ID: 105839
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I, Tunevall G.
    Scand J Infect Dis Suppl; 1980 May 30; Suppl 23():39-44. PubMed ID: 6782657
    [Abstract] [Full Text] [Related]

  • 17. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A, Montini G, Ramacciotti PG.
    Chemioterapia; 1985 Dec 30; 4(6):439-44. PubMed ID: 3830413
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C, Barry AL, Jones RN, Baker CN, Badal RE, Packer RR.
    Antimicrob Agents Chemother; 1980 Aug 30; 18(2):338-45. PubMed ID: 7447410
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.